Results 31 to 40 of about 1,308,546 (203)

Invasive Aspergillosis in Patients with Chronic Obstructive Pulmonary Diseases [PDF]

open access: yes, 2005
OBJECTIVES: To determine the outcomes, and clinical and therapeutic factors associated with the development of invasive pulmonary aspergillosis (IPA) in patients with obstructive pulmonary ...
Aziz Muquim   +3 more
core   +1 more source

Pulmonary Aspergillosis: An Evolving Challenge for Diagnosis and Treatment

open access: yesInfectious Diseases and Therapy, 2020
Aspergillus is a mold that may lead to different clinical pictures, from allergic to invasive disease, depending on the patient’s immune status and structural lung diseases.
Alessandro Russo   +3 more
doaj   +1 more source

Endpoint Assessment in Rabbit Models of Invasive Pulmonary Aspergillosis and Mucormycosis. [PDF]

open access: yes, 2017
Multiple animal models have been developed to study the pathogenesis of invasive pulmonary aspergillosis, as well as to evaluate the efficacy, pharmacokinetics, and pharmacodynamics of various antifungal agents and vaccines.
Thomas J. Walsh   +7 more
core   +1 more source

Recovery of a triazole-resistant Aspergillus fumigatus in respiratory specimen of COVID-19 patient in ICU – A case report

open access: yesMedical Mycology Case Reports, 2021
Although invasive pulmonary aspergillosis (IPA) is typically described in immunocompromised host, patient with severe influenzae can develop IPA. Similarly, patients with severe COVID-19 complicated with IPA are increasingly reported. Here, we describe a
Théo Ghelfenstein-Ferreira   +8 more
doaj   +1 more source

Correlation Between CT Findings of Invasive Pulmonary Aspergillosis and Severity of Neutropenia

open access: yesSiriraj Medical Journal, 2019
Objective: The purpose of this study was to investigate the association between CT findings of invasive pulmonary aspergillosis and neutrophils level. Methods: This retrospective study included the patients diagnosed with invasive pulmonary aspergillosis
Suwimon Wonglaksanapimon   +2 more
doaj   +3 more sources

Chronic pulmonary aspergillosis - case series and review of Indian literature

open access: yesIndian Journal of Respiratory Care, 2021
Aspergillus species, especially Aspergillus fumigatus, can cause varied pulmonary manifestations depending on the host immune status and duration of infection. Chronic pulmonary aspergillosis (CPA) is an under-reported entity, and its diagnosis remains a
Vikas Marwah   +6 more
doaj   +1 more source

Subacute invasive pulmonary aspergillosis in a nondiabetic immunocompetent female suffering from allergic broncho pulmonary aspergillosis

open access: yes, 2023
A 55-year-old female presented with recent exacerbation of the chronic cough, dyspnea, and copious expectoration. The symptoms worsened during the winter months. In the past, she was misdiagnosed with pulmonary tuberculosis.
Vivek Hada   +3 more
core   +1 more source

Successful Off-Label Use of Recombinant Factor VIIa and Coil Embolization in an Adolescent with Massive Hemoptysis Due to Invasive Pulmonary Aspergillosis

open access: yesTurkish Journal of Hematology, 2015
Invasive fungal infections have turned out to be a significant cause of morbidity and mortality in pediatric patients with malignant disorders. Massive hemoptysis, a rare complication of invasive pulmonary aspergillosis, may threaten the lives of ...
Dilek Gürlek Gökçebay   +4 more
doaj   +1 more source

Pulmonary aspergillosis associated with antineutrophil cytoplasmic antibody-positive vasculitis involving skin and peripheral nerves

open access: yesJournal of the Indian Academy of Geriatrics
Invasive pulmonary aspergillosis is the most common cause of invasive fungal infection. Vasculitis secondary to bacterial, fungal, viral, and parasitic infections is documented in the literature.
Abhijith Rajaram Rao   +3 more
doaj   +1 more source

Fulminant invasive aspergillosis of the mediastinum in an immunocompetent host: a case report

open access: yesJournal of Medical Case Reports, 2012
Introduction Invasive aspergillosis is a serious complication in immunocompromised patients. It is an opportunistic disease, which predominantly occurs in the lungs, although dissemination to virtually any organ is possible.
Shakoor Muhammad   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy